MONONUCLEAR CELL SUBPOPULATIONS AND CYTOKINE LEVELS IN HUMAN VISCERAL LEISHMANIASIS BEFORE AND AFTER CHEMOTHERAPY

被引:79
作者
CENINI, P [1 ]
BERHE, N [1 ]
HAILU, A [1 ]
MCGINNES, K [1 ]
FROMMEL, D [1 ]
机构
[1] UNIV ADDIS ABABA, INST PATHOBIOL, ADDIS ABABA, ETHIOPIA
关键词
D O I
10.1093/infdis/168.4.986
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum cytokine levels and mononuclear cell subpopulations in the spleen and peripheral blood of patients with visceral leishmaniasis before and after antimony therapy were analyzed. The percentages of activated monocytes/macrophages, T cells, and possibly B cells; of gamma/delta T cell receptor (TCR)-bearing T cells; of CD4- CD8- alpha/beta TCR-bearing T cells; and serum levels of tumor necrosis factor-alpha (TNFalpha), interferon-gamma (IFN-gamma), and interleukin-6 (IL-6) were high in patients with active visceral leishmaniasis. The proportion of both helper and suppressor CD4+ cells and of cells with NK and cytotoxic T phenotypes were depressed. Successful chemotherapy normalized these parameters with the exception of activated monocytes. Thus, the impaired cell-mediated immunity in human Leishmania donovani infection is primarily due to a decrease in the proportion and possibly the activity of helper CD4+ cells, while suppressor cells do not seem to play a relevant role. TNFalpha, IL-6, and IFN-gamma may prove to be useful markers for monitoring response to therapy.
引用
收藏
页码:986 / 993
页数:8
相关论文
共 52 条
[1]   THE APPEARANCE OF T-CELLS BEARING SELF-REACTIVE T-CELL RECEPTOR IN THE LIVERS OF MICE INJECTED WITH BACTERIA [J].
ABO, T ;
OHTEKI, T ;
SEKI, S ;
KOYAMADA, N ;
YOSHIKAI, Y ;
MASUDA, T ;
RIKIISHI, H ;
KUMAGAI, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (02) :417-424
[2]  
ADERKA D, 1989, J IMMUNOL, V143, P3517
[3]  
ARMITAGE P, 1987, STATISTICAL METHODS
[4]   THE DISTRIBUTION OF VISCERAL LEISHMANIASIS IN ETHIOPA [J].
AYELE, T ;
ALI, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1984, 33 (04) :548-552
[5]   TREATMENT OF VISCERAL LEISHMANIASIS WITH PENTAVALENT ANTIMONY AND INTERFERON-GAMMA [J].
BADARO, R ;
FALCOFF, E ;
BADARO, FS ;
CARVALHO, EM ;
PEDRALSAMPAIO, D ;
BARRAL, A ;
CARVALHO, JS ;
BARRALNETTO, M ;
BRANDELY, M ;
SILVA, L ;
BINA, JC ;
TEIXEIRA, R ;
FALCOFF, R ;
ROCHA, H ;
HO, JL ;
JOHNSON, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :16-21
[6]   TUMOR-NECROSIS-FACTOR (CACHECTIN) IN HUMAN VISCERAL LEISHMANIASIS [J].
BARRALNETTO, M ;
BADARO, R ;
BARRAL, A ;
ALMEIDA, RP ;
SANTOS, SB ;
BADARO, F ;
PEDRALSAMPAIO, D ;
CARVALHO, EM ;
FALCOFF, E ;
FALCOFF, R .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :853-857
[7]  
Bray R.S., 1987, P211
[8]  
BUCY RP, 1989, J IMMUNOL, V142, P3045
[9]   CELL-MEDIATED-IMMUNITY IN AMERICAN VISCERAL LEISHMANIASIS - REVERSIBLE IMMUNOSUPPRESSION DURING ACUTE INFECTION [J].
CARVALHO, EM ;
TEIXEIRA, RS ;
JOHNSON, WD .
INFECTION AND IMMUNITY, 1981, 33 (02) :498-502
[10]   ANTIGEN-SPECIFIC IMMUNOSUPPRESSION IN VISCERAL LEISHMANIASIS IS CELL-MEDIATED [J].
CARVALHO, EM ;
BACELLAR, O ;
BARRAL, A ;
BADARO, R ;
JOHNSON, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (03) :860-864